Skip to main content
Premium Trial:

Request an Annual Quote

Gender Inequality in Biotech Boardrooms

Through an analysis of nearly 1,500 biotech companies in the US and Europe, executive search recruitment firm Liftstream reports that women are underrepresented among the upper echelon of executives in the sector.

According to the company's report, nearly 60 percent of the boardrooms of small and medium-sized enterprises in Europe and 52 percent of them in the US are all male. Additionally, among companies of that size, 11.2 percent in Europe and 9.7 percent in the US have female directors, and an average 21.7 percent and 20.8 percent of their management team in Europe and the US, respectively, are women.

Among big biotech companies — those with more than 1,000 employees — 19.2 percent have female directors, and an average 13.9 percent of their leadership teams are female.

"The biotech sector faces considerable challenges in meeting its board and executive leadership requirements," says Karl Simpson, the Liftstream CEO, in a statement. "However, this detailed research shows that gender inequality remains a significant problem at the top of companies."

The Liftstream report suggests that CEOs and chairs take a deep look into their recruiting and promoting practices, evaluate the training and support given to female talent, and lead discussions in the boardroom about diversity.

The Scan

Steps for Quick Review

The US Food and Drug Administration is preparing for the quick review of drugs and vaccines for the Omicron variant, according to the Wall Street Journal.

Moving Away From Using Term 'Race'

A new analysis finds that geneticists are using the term "race" in their papers less than in years past, as Science reports.

Point of the Program

The Guardian writes that some scientists have called the design of a UK newborn sequencing program into question.

Science Papers Present Multi-Omic Analysis of Lung Cells, Regulation of Cardiomyocyte Proliferation

In Science this week: a multi-omic analysis of lung cells focuses on RIT1-regulated pathways, and more.